Provider profile
Labcorp.
Bioanalytical services
Labcorp's biopharma lab business describes bioanalytical services: method development, validation and sample analysis, PK/TK, immunogenicity, biomarker and molecular assays on LC-MS/MS and ligand-binding platforms, for small molecules, peptides, antibodies, ADCs, oligonucleotides and cell and gene therapies, preclinical to Phase III. Named bioanalysis sites: Greenfield (US), Harrogate (UK), Shanghai, Singapore.
- Website
- labcorp.com (opens in a new tab)
- Sources reviewed
- November 3, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
- Biomarker assays3,8Stated for clinical biomarker services in Singapore
- Cell-based assays8Stated for immunology and immunotoxicology services in China
- Flow cytometry8Stated for immunology and immunotoxicology services in China
- Immunogenicity (ADA/NAb)2
- Method development1,2
- Method validation1,3
- Molecular assays (qPCR/ddPCR)6
- PK/TK bioanalysis2,4
- Regulated study-sample analysis1,2
Development experience
Development experience
Locations
Locations
- Shanghai, China · Laboratory6Listed as a molecular bioanalysis site; the China page also describes LC-MS/MS and immunochemistry bioanalysis in China
- Singapore · Laboratory3Bioanalytical facility; also listed as a molecular bioanalysis site
- Harrogate, United Kingdom · Laboratory6Listed as a molecular bioanalysis site
- Greenfield, United States · Laboratory6Listed as a molecular bioanalysis site
Quality and regulatory
Quality and regulatory
The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Whether a validated method already exists for your molecule or a close analogue, and who owns it
- Validation scope against ICH M10 for your assay type, and expected timeline
- Current instrument and analyst capacity, and turnaround per sample batch
- Sample receipt, storage conditions, chain of custody and international shipping experience
- Most recent regulatory inspection or audit outcomes relevant to your studies
- Data-integrity controls and the format of data delivered to your PK or biometrics vendor
Evidence and sources
Evidence and sources
- 1Specialty LC-MS | Labcorp (opens in a new tab)Labcorp Drug Development · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2LC-MS Bioanalytical Testing & Services | Labcorp (opens in a new tab)Labcorp Drug Development · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Singapore Lab Services for Drug Development | Labcorp (opens in a new tab)Labcorp · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Sample Anaysis | Labcorp (opens in a new tab)Labcorp Drug Development · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Bioanalysis & Bioanalytical Services with LC MS Methods | Labcorp (opens in a new tab)Labcorp Drug Development · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 6Molecular Bioanalysis Services & Assays | Labcorp (opens in a new tab)Labcorp Drug Development · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 7Molecular Assay Development and Bioanalysis | Labcorp | Labcorp (opens in a new tab)Labcorp Drug Development · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 8Drug development capabilities in China | Labcorp (opens in a new tab)Labcorp · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 9Immunoanalytical | Labcorp (opens in a new tab)Labcorp · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.